Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 278 of 6351
-
Heart attack without blockage: trial tests gentler blood thinners for SCAD
Disease control Not yet recruitingSpontaneous coronary artery dissection (SCAD) is a rare cause of acute coronary syndrome in which blood flow to the heart muscle is reduced or interrupted. It predominantly affects women between 30 and 55 years of age and typically occurs in the absence of atherosclerosis. For ma…
Phase 4 • Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can mindfulness after injury curb opioid dependence?
Prevention Not yet recruitingThe goal of this proposed project is to optimize the adaptive psychological intervention and assess the feasibility and acceptability. The long-term objective of this line of research is to evaluate whether an adaptive psychological intervention delivered after a musculoskeletal …
Sponsor: Henry Ford Health System • Aim: Prevention
Last updated Aug 12, 2026 00:00 UTC
-
Can a phone app ease suicidal thoughts in young adults?
Symptom relief Not yet recruitingThis study will evaluate the effectiveness of MindBridge, a dialectical behavior therapy (DBT)-informed mobile health module delivered through a WeChat mini-program, among Chinese young adults aged 18 to 24 years with mild-to-moderate suicide risk. In the randomized controlled tr…
Sponsor: Jiangsu Medical College • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Experimental cell therapy takes on Drug-Resistant melanoma
Disease control Not yet recruitingThe protocol is a Simon's 2-stage, non-randomized, open label, multi-site, phase 2 trial for patients with advanced metastatic, recurrent and unresectable malignant melanoma that has recurred or relapsed after prior anti-PD-(L)1 therapy.
Phase 2 • Sponsor: Rapa Therapeutics LLC • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could a pill plus walking ease knee pain and lift mood in veterans?
Symptom relief Not yet recruitingKnee osteoarthritis (KOA) is one of the most common causes of chronic pain, mobility problems, and disability among United States Veterans. Many Veterans with KOA also experience depressive symptoms, which can worsen pain, reduce motivation to exercise, and make recovery more dif…
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Digital therapy aims to tame the fear that haunts cancer survivors
Symptom relief Recruiting nowThis clinical trial studies whether an intervention supported by technology (blended e-health intervention) works to improve fear of progression (FOP) in women with gynecologic or breast cancer. FOP is the fear patients experience from the possibility that their cancer could grow…
Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Can a RAGE inhibitor tame brain swelling after tumor surgery?
Disease control Not yet recruitingThis phase I trial tests the safety, side effects, best dose and how well FPS-ZM1 works for controlling post operative cerebral edema in patients with glioblastoma. FPS-ZM1 works by blocking the pathway that controls inflammation. Dexamethasone is in a class of medications called…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a new pill help older adults lose weight without losing strength?
Disease control Not yet recruitingThis is a phase 2 randomized, double-blind, placebo-controlled, multi-center study evaluating the efficacy and safety of LUM-201 plus Semaglutide versus Semaglutide plus placebo in obese adults with body mass index between 30 and 45 kg/m\^2, between the ages of 60 and 85 years th…
Phase 2 • Sponsor: Lumos Pharma • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a new drug combo outsmart resistant breast cancer?
Disease control Not yet recruitingTo find the optimal (best) recommended dose of zotatifin and carboplatin to treat patients with metastatic or recurrent TNBC.
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug duo aims to shrink tough head and neck tumors
Disease control Not yet recruitingThe goal of this clinical trial is to learn if the combination of cemiplimab and fianlimab can improve outcomes compared to cemiplimab alone in adults with Human Papillomavirus Positive HPV-positive head and neck cancer.
Phase 2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New hope for young AML patients: targeted drug combo tested in phase 2 trial
Disease control Recruiting nowThis phase II MYELOMATCH treatment trial compares the effect of venetoclax to gemtuzumab ozogamicin, when given with cytarabine and daunorubicin ("7+3" regimen), for the treatment of patients with core binding factor acute myeloid leukemia (CBF-AML). Venetoclax is in a class of m…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 03:00 UTC
-
Can an RNA 'Message' reprogram the immune system to stop autoimmune blood disorders?
Disease control Not yet recruitingThe Phase 1 is to evaluate the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of RXIM002 in patients with relapsed or refractory autoimmune cytopenias.
Phase 1 • Sponsor: RiboX Therapeutics Ltd. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
A urine test may boost HIV prevention — a trial puts it to the test
Disease control Not yet recruitingThe goal of this randomized trial study is to learn if drug-level feedback counseling works to improve oral PrEP adherence in adolescent girls and young women. Researchers will compare urine TFV assay positivity between arms. All participants will attend visits on the same sched…
Sponsor: University of Washington • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
A text a day: could smartphone prompts curb HIV risk?
Prevention Not yet recruitingProject SPACE is a micro-randomized trial evaluating the proximal effects theory-based text messages on alcohol use and sexual HIV risk behaviors among HIV-negative young adult men at the day-level. At baseline, all participants will complete GamePlan, an existing brief online s…
Sponsor: Emory University • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
A gentler sugar may steady blood glucose after workouts in type 1 diabetes
Disease control Not yet recruitingThis Ph.D. project investigates whether orally ingested galactose can be taken up by skeletal muscle and the heart in response to exercise or hyperinsulinemia, and whether it may serve as a viable nutritional strategy for individuals with type 1 diabetes (T1D). Although exercise…
Sponsor: University of Aarhus • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Could yoga ease the toll of stem cell transplants?
Symptom relief Not yet recruitingThe purpose of this study is to learn whether a yoga therapy program can improve quality of life and reduce symptoms in people undergoing stem cell transplantation compared with an enhanced standard care physical activity program.
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Can a short CBT session curb Post-Surgery opioid dependence?
Symptom relief Not yet recruitingThis study aims to evaluate the impact of a Transitional Pain Service (TPS) on hospital readmission rates, opioid consumption, and chronic post-surgical pain(CPSP), Despite increasing recognition of the benefits of integrated transitional pain care, there are limited prospective …
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
Cooling the pancreas from the inside: a new device aims to tame severe inflammation
Disease control Not yet recruitingResearchers will compare people who get the ACC Set plus standard of care to people who get standard of care alone. This will show whether adding the ACC Set helps. Participants will: Join one of two groups, chosen by chance: the ACC Set plus standard of care, or standard of ca…
Sponsor: Arctx Medical, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can cannabis calm War's ghosts? new trial for vets with PTSD
Symptom relief Not yet recruitingThe rationale for the use of inhalational cannabis to potentially treat PTSD symptoms is based on the many reports of cannabis attenuating PTSD symptom expression among individuals with PTSD, including veterans. Study MJP2 is intended to build off MJP-1 through use of a larger sa…
Phase 2 • Sponsor: Multidisciplinary Association for Psychedelic Studies • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Mindfulness on your phone: a new test for sickle cell pain and sleep
Symptom relief Not yet recruitingThis study examines the efficacy of a mindfulness-based intervention designed to support pain and sleep management in adolescents and young adults with sickle cell disease. Participants will be assigned to either an intervention or usual care group. Participants who are assigned …
Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC